Celularity Inc (CELU)
2.76
-0.09
(-3.16%)
USD |
NASDAQ |
Nov 22, 16:00
2.77
+0.01
(+0.36%)
After-Hours: 20:00
Celularity Gross Profit Margin (Quarterly): 82.47% for June 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 82.47% |
| March 31, 2024 | 88.83% |
| December 31, 2023 | 20.67% |
| September 30, 2023 | 4.86% |
| June 30, 2023 | 72.70% |
| March 31, 2023 | 49.10% |
| December 31, 2022 | -27.08% |
| September 30, 2022 | -74.44% |
| Date | Value |
|---|---|
| June 30, 2022 | 15.81% |
| March 31, 2022 | 32.17% |
| December 31, 2021 | 4.04% |
| September 30, 2021 | 78.24% |
| June 30, 2021 | 54.96% |
| March 31, 2021 | 53.31% |
| December 31, 2020 | 63.92% |
| September 30, 2020 | 69.21% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-74.44%
Minimum
Sep 2022
88.83%
Maximum
Mar 2024
36.80%
Average
51.20%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Eli Lilly and Co | 81.02% |
| Dentsply Sirona Inc | 52.05% |
| Ligand Pharmaceuticals Inc | 95.27% |
| NovaBay Pharmaceuticals Inc | 65.26% |
| Palatin Technologies Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -226.8% |
| Return on Assets | -68.23% |
| Return on Invested Capital | -128.9% |
| Profit Margin (Quarterly) | -53.57% |
| Operating Margin (Quarterly) | -84.01% |
| Return on Net Operating Assets | -86.72% |